Parexel Industry Insights

1. Lessons From The Front Lines: Navigating The Operational Challenges Of Next-Generation ADC Trials 9/22/2026

   See how smarter protocol design and real-time safety monitoring can ease patient burden and keep next-gen ADC oncology trials on track.

2. Turning Urgency Into Progress And Advancing New Hope In AML 9/22/2026

   A disrupted AML trial stabilized mid-study, cutting genetic testing turnaround to 1–2 days and keeping enrollment on track for patients who can't wait.

3. Rescue Treatment Design In Wet AMD And Retinal Vascular Trials 9/22/2026

   How trials protect vision without muddying the data: explore the five design choices behind an effective rescue treatment strategy.

4. Strategic ADC Development In A Shifting Regulatory Landscape 8/28/2026

   As ADC development grows more complex, sponsors must align safety, dose optimization, global trial design, regulatory strategy and CMC readiness early to reduce risk and accelerate approval.

5. Next-Generation ADC Trials – Turning Complexity Into Execution 7/20/2026

   As ADC science advances, operational strategy becomes critical. Learn how smarter protocol design, real-time monitoring and collaborative execution can accelerate next-generation ADC trials.

6. At The Turning Point – Shaping The Future Of Hematology 7/20/2026

   Hematology is at a turning point. Turn complexity into strategy with smarter trial design, stronger patient engagement, confident regulatory navigation and real-world evidence insights.

7. The Lasting Impact Of Treatment Gaps In ARG1-D 6/26/2026

   A patient story from ARG1-D reveals how even brief treatment interruptions can trigger irreversible decline and why continuity of care must remain a priority in rare disease research.

8. Genetic Therapies Bootcamp Highlights From ACMG 2026 Meeting 6/26/2026

   Review of ACMG 2026 Genetic Therapies Bootcamp, including gene therapy, gene editing, ASOs, rare disease trial design, and the evolving role of genetics professionals.

9. Executing Pediatric Gene Therapy Trials At The Site Level 5/29/2026

   Pediatric gene therapy trials demand exceptional coordination at the site level, and these frontline insights can help you manage protocol complexity and balance operations with family‑centered care.

10. Navigating The Challenges Of Large, International Phase III Breast Cancer Trials 5/27/2026

    In the competitive landscape of breast cancer research, aligning biomarker testing, regulatory pathways, and regional operations from day one creates a path to faster enrollment and stronger outcomes.